Document Detail


Current indications for ACE inhibitors and HOPE for the future.
MedLine Citation:
PMID:  12019599     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Angiotensin-converting enzyme (ACE) inhibitors are effective in several disease states such as congestive heart failure, myocardial infarction, and diabetes. This article reviews the evidence supporting the clinical use, efficacy, and cost effectiveness of ACE inhibitors in these various disease states. With the findings of the Heart Outcomes Prevention Evaluation trial, these agents may now have a positive impact on the primary prevention of coronary artery disease. New and ongoing trials will provide more information about the role of ACE inhibitors in coronary artery disease.
Authors:
Stephanie Burch; Narith Ou
Related Documents :
17245479 - Improving outcomes in chronic heart failure.
26329 - On the mode of action of antianginal drugs.
22812589 - Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis.
22243999 - Ejection fraction change and coronary artery disease severity: a vasodilator contrast s...
22415819 - Does quantification of myocardial flow reserve using rubidium-82 positron emission tomo...
22424329 - Left ventricle assist device: when and which patients should we refer?
21067399 - Myocardial fibrosis in hypertrophic cardiomyopathy.
3446159 - Tc-99m tertiary butyl isonitrile: a preliminary clinical study of a new myocardial imag...
18625529 - Statins and prevention of atrial fibrillation in patients with heart failure.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The American journal of managed care     Volume:  8     ISSN:  1088-0224     ISO Abbreviation:  Am J Manag Care     Publication Date:  2002 May 
Date Detail:
Created Date:  2002-05-21     Completed Date:  2002-06-10     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9613960     Medline TA:  Am J Manag Care     Country:  United States    
Other Details:
Languages:  eng     Pagination:  478-90; quiz 491-3     Citation Subset:  H    
Affiliation:
Heartland Health, St Joseph, MO 65406-3398, USA. stephanie.burch@mail.heartland-health.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin-Converting Enzyme Inhibitors / adverse effects,  contraindications,  pharmacology,  therapeutic use*
Arteriosclerosis / prevention & control
Cardiovascular Diseases / drug therapy*,  prevention & control*
Clinical Trials as Topic
Diabetic Nephropathies / prevention & control
Economics, Pharmaceutical
Education, Continuing
Heart Failure / drug therapy
Humans
Hypertension / drug therapy
United States
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The SF-36 general health status survey documents the burden of osteoarthritis and the benefits of to...
Next Document:  Flaking corn: processing mechanics, quality standards, and impacts on energy availability and perfor...